We have located links that may give you full text access.
Industrial update.
Therapeutic Delivery 2014 November
The current industry update covers the period 1-31 August 2014, with the information largely based on company press releases, and news from regulatory agencies, patents and various news websites. On the product approval front, Genzyme, The Medicines Company, Merck, Sharpe & Dohme Corporation, Genentech/Roche, and Boehringer Ingelheim-Eli Lilly reported approval of new products. There was promising news on the clinical trial front for the experimental vaccine to prevent the mosquito-borne viral disease 'chikungunya'. The recent multibillion-dollar deal in the pharma sector is the acquisition of InterMune Inc., a California-based biotech firm, by Roche Holding AG. Also, Cilag GmbH International has announced acquisition of Covagen AG, a privately-held biopharmaceutical company.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app